[患有BRCA2致病突变的前列腺癌:临床病理学分析]
1Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041,China.
Zhonghua bing li xue za zhi = Chinese journal of pathology
|August 5, 2024
概括
在侵袭性前列腺癌中,BRCA2基因突变很常见. 虽然DNA损伤修复基因突变缩短了生存期,但BRCA2突变在本研究中没有显著影响整体生存期.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 前列腺癌是男性癌症相关死亡的主要原因.
- BRCA2基因突变与各种癌症的风险增加和侵略性形式有关,包括前列腺癌.
- 了解前列腺癌中与BRCA2突变相关的临床病理特征和生存结果对于患者管理至关重要.
研究的目的:
- 为了研究患有BRCA2致病突变的前列腺癌的临床病理学特征.
- 确定BRCA2致病突变与特定临床病理特征之间的关联.
- 为了检查BRCA2突变对患者存活率的影响.
主要方法:
- 对249名经过基因检测的前列腺癌患者进行了回顾性分析.
- 收集和分析了他的病理形态学,临床病理学特征和患者生存数据.
- 鉴定了DNA损伤修复基因 (DRG) 的致病突变,包括BRCA2 (生殖和体质).
主要成果:
- 29.3%的患者患有DRG突变;8.8%患有BRCA2突变 (5.6%生殖系,3.2%体质).
- 发生BRCA2突变的前列腺癌经常呈现高格里森得分 (≥8),远程转移,割抵抗和前列腺导管内癌 (IDC-P).
- 患有任何DRG突变的患者的整体存活期 (OS) 比没有 (P=0.040) 的患者要短;BRCA2突变没有显著影响OS (P=0.216).
结论:
- BRCA2病原性突变在高等级,晚期和割抵抗性前列腺癌中普遍存在.
- 前列腺导管内癌 (IDC-P) 在患有BRCA2生殖系突变的患者中更常见.
- 虽然DRG突变与减少的OS有关,但单独的BRCA2突变在这个队列中与生存结果没有显著的关联.
更多相关视频
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
16.5K
13:04In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
13.1K
相关概念视频
01:21Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K